Excellent Prognosis of Patients with Nonhereditary Medullary Thyroid Carcinoma with Ultrasonographic Findings of Follicular Tumor or Benign Nodule

  • Mitsuhiro Fukushima
  • Yasuhiro Ito
  • Mitsuyoshi Hirokawa
  • Akihiro Miya
  • Kaoru Kobayashi
  • Haruki Akasu
  • Kazuo Shimizu
  • Akira Miyauchi
Article

Abstract

Background

Medullary thyroid carcinoma (MTC) accounts for only 1.4% of all thyroid malignancies in Japan. Generally, MTC shows ultrasonographic findings typical of thyroid carcinoma. However, in our experience, some MTC may be diagnosed as a follicular tumor or a benign nodule on ultrasonography because ultrasonographic findings of malignancy are lacking. In this study we investigated differences in biological behavior between these two types of MTC.

Methods

Seventy-seven patients with nonhereditary MTC who underwent surgery in our department between 1988 and 2007 were enrolled in this study. Of these patients, 54 were diagnosed as having thyroid carcinoma (malignant, or M-type) but the remaining 23 were diagnosed as having follicular tumor or benign nodule (benign, or B-type) on ultrasonography.

Results

Clinically apparent lateral node metastasis, extrathyroid extension, and extranodal tumor extension were observed in 37%, 17%, and 11% of M-type patients, respectively, but none of the B-type patients showed any of these features. All B-type patients but only 59% of M-type patients were biochemically cured. Lymph node metastasis was pathologically confirmed in 38 and 65% of B-type and M-type patients, respectively. Eight patients showed recurrence and three have died of carcinoma to date; all of these patients were M-type patients.

Conclusions

B-type MTC is highly indolent and shows an excellent prognosis. However, thyroidectomy and lymph node dissection for B-type MTC should be the same as for M-type MTC because 38% of B-type MTC showed pathologic node metastasis.

References

  1. 1.
    Ezaki H, Ebihara S, Fujimoto Y et al (1992) Analysis of thyroid carcinoma based on material registered in Japan during 1977–1986 with special reference to predominance of papillary type. Cancer 70:808–814PubMedCrossRefGoogle Scholar
  2. 2.
    Moley JE, DeBenedetti MK (1999) Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg 229:880–887PubMedCrossRefGoogle Scholar
  3. 3.
    Kebebew E, Ituarte PH, Siperstein AE et al (2000) Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88:1139–1148PubMedCrossRefGoogle Scholar
  4. 4.
    Gulben K, Berberoglu U, Boyabatl M (2006) Prognostic factors for sporadic medullary thyroid crcinoma. World J Surg 30:84–90PubMedCrossRefGoogle Scholar
  5. 5.
    DeLellis RA, Rule AH, Spiler I et al (1978) Calcitonin and carcinoembryonic antigen as tumor markers in medullary thyroid carcinoma. Am J Clin Pathol 70:587–594PubMedGoogle Scholar
  6. 6.
    Raue R, Kkotzerke J, Reinwein D et al (1993) Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German medullary thyroid carcinoma register. Clin Invest 71:7–12CrossRefGoogle Scholar
  7. 7.
    Mulligan LM, Kwok JB, Healey C et al (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 2:851–856Google Scholar
  8. 8.
    Donis-Keller H, Dou S, Chi D et al (1993) Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum Mol Genet 2:851–856PubMedCrossRefGoogle Scholar
  9. 9.
    Carlson KM, Dou S, Chi D et al (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91:1579–1583PubMedCrossRefGoogle Scholar
  10. 10.
    Hyer SL, Newbold K, Harmer C (2005) Familial medullary thyroid cancer: clinical aspects and prognosis. Eur J Surg Oncol 31:415–419PubMedCrossRefGoogle Scholar
  11. 11.
    Cupisti K, Wolf A, Raffel A et al (2007) Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution’s experience over 20 years. Ann Surg 246:815–821PubMedCrossRefGoogle Scholar
  12. 12.
    Lee NC, Norton JA (2000) Multiple endocrine neoplasia type 2B—genetic basis and clinical expression. Surg Oncol 9:111–118PubMedCrossRefGoogle Scholar
  13. 13.
    Brauckhoff M, Gimm O, Weiss CL et al (2004) Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease. World J Surg 28:1305–1311PubMedCrossRefGoogle Scholar
  14. 14.
    Bergholm U, Bergstrom R, Ekbom A (1997) Long-term follow-up of patients with medullary carcinoma of the thyroid. Cancer 79:132–138PubMedCrossRefGoogle Scholar
  15. 15.
    Kameyama K, Takami H (2004) Medullary thyroid carcinoma: Nationwide Japanese survey of 634 cases in 1996 and 271 cases in 2002. Endocr J 51:453–456PubMedCrossRefGoogle Scholar
  16. 16.
    Ito Y, Amino N, Ota H et al (2007) Ultrasonographic evaluation of thyroid nodules in 900 patients: comparison among ultrasonographic, cytological, and histological findings. Thyroid 17:1269–1276PubMedCrossRefGoogle Scholar
  17. 17.
    Yokozawa T, Fukata S, Kuma K et al (1996) Thyroid cancer detected by ultrasound-guided fine-needle aspiration biopsy. World J Surg 20(7):848–853; discussion 853PubMedCrossRefGoogle Scholar
  18. 18.
    Papaparaskeva K, Nagel H, Droese M (2000) Cytologic diagnosis of medullary carcinoma of the thyroid. Diagn Cytopathol 22:351–358PubMedCrossRefGoogle Scholar
  19. 19.
    Bugalho MJ, Santos JR, Sobrinho L (2005) Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol 91:56–60PubMedCrossRefGoogle Scholar
  20. 20.
    Kudo T, Miyauchi A, Ito Y et al (2007) Diagnosis of medullary thyroid carcioma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid 17:635–638PubMedCrossRefGoogle Scholar
  21. 21.
    Ito Y, Miyauchi A, Yabuta T et al (2009) Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: Experience of a single institution. World J Surg 33:58–66PubMedCrossRefGoogle Scholar
  22. 22.
    Gharib H, McConahey WM, Tiegs RD et al (1992) Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. Mayo Clinic Proc 67:934–940Google Scholar
  23. 23.
    Miyauchi A, Matsuzuka F, Hirai K et al (2000) Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma. World J Surg 24:1367–1372PubMedCrossRefGoogle Scholar
  24. 24.
    Sobin LH, Wittekind CH (eds) (2002) UICC: TNM classification of malignant tumors, 6th edn. Wiley-Liss, New YorkGoogle Scholar
  25. 25.
    Saad MF, Ordonez NG, Rashid RK (1984) Medullary carcinoma of the thyroid: a study of the clinical features and prognostic factors in 161 patients. Medicine 63:319–342PubMedCrossRefGoogle Scholar
  26. 26.
    Brierley J, Tsang R, Simpson WJ (1996) Medullary thyroid cancer: analysis of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 6:305–310PubMedCrossRefGoogle Scholar
  27. 27.
    Dottorini ME, Assi A, Sironi M (1996) Multivariate analysis of patients with medullary carcinoma: prognostic significance and impact on treatment of clinical and pathologic variables. Cancer 77:1556–1565PubMedCrossRefGoogle Scholar
  28. 28.
    Clark JR, Friedman TR, Odell MJ (2005) Prognostic variables and calcitonin in medullary thyroid cancer. Laryngoscope 115:1145–1150CrossRefGoogle Scholar
  29. 29.
    Machens A, Hofmann C, Hauptmann S et al (2007) Locoregional recurrence and death from medullary thyroid carcinoma in a contemporaneous series: 5-year results. Eur J Endocrinol 157:85–93PubMedCrossRefGoogle Scholar
  30. 30.
    Schroder S, Bocker W, Baisch H et al (1988) Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content. Cancer 61:806–816PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2009

Authors and Affiliations

  • Mitsuhiro Fukushima
    • 1
  • Yasuhiro Ito
    • 1
  • Mitsuyoshi Hirokawa
    • 2
  • Akihiro Miya
    • 1
  • Kaoru Kobayashi
    • 1
  • Haruki Akasu
    • 3
  • Kazuo Shimizu
    • 3
  • Akira Miyauchi
    • 1
  1. 1.Department of SurgeryKuma HospitalKobe CityJapan
  2. 2.Department of PathologyKuma HospitalKobe CityJapan
  3. 3.Department of SurgeryNippon Medical SchoolTokyoJapan

Personalised recommendations